Search

Your search keyword '"Chaudhry, Vinay"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Chaudhry, Vinay" Remove constraint Author: "Chaudhry, Vinay" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
35 results on '"Chaudhry, Vinay"'

Search Results

1. Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America

2. Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial

3. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

4. Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

5. A Genome-Wide Association Study of Myasthenia Gravis

7. Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: Real world experience from 27 centres

8. Proceedings of the 2023 Global Polytechnic Summit, Technology Talent: Advancing a Comprehensive and Global Strategy

9. A comprehensive study of skeletal muscle imaging in FHL1‐related reducing body myopathy

10. Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS

15. Improving the efficacy of exome sequencing at a quaternary care referral centre: novel mutations, clinical presentations and diagnostic challenges in rare neurogenetic diseases

17. Risk Factors for Infection and Health Impacts of the Coronavirus Disease 2019 (COVID-19) Pandemic in People With Autoimmune Diseases

18. RISK FACTORS FOR INFECTION AND HEALTH IMPACTS OF THE COVID-19 PANDEMIC IN PEOPLE WITH AUTOIMMUNE DISEASES

19. Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis

20. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

21. Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

22. Risk Factors for Infection and Health Impacts of the Coronavirus Disease 2019 (COVID-19) Pandemic in People With Autoimmune Diseases.

23. Long-term safety and efficacy of eculizumab in generalized myasthenia gravis

24. Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: Real world experience from 27 centres

25. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

26. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

27. A Genome-Wide Association Study of Myasthenia Gravis

28. Peripheral Neuropathy Research Registry: A prospective cohort.

30. Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial.

31. Sweat Gland Denervation in Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome ( CANVAS).

32. Vitamin D levels do not correlate with severity of idiopathic peripheral neuropathy.

33. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

34. RISK FACTORS FOR INFECTION AND HEALTH IMPACTS OF THE COVID-19 PANDEMIC IN PEOPLE WITH AUTOIMMUNE DISEASES.

35. Assessing mNIS+7 Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial.

Catalog

Books, media, physical & digital resources